Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I Studies
Crossref DOI link: https://doi.org/10.1007/s40261-016-0419-6
Published Online: 2016-06-29
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fossler, Michael
Zhu, John
Roehrborn, Claus
McAleese, Paul
Manyak, Michael
Funding for this research was provided by:
GlaxoSmithKline (GB)
License valid from 2016-06-29